In conclusion, the present data provides evidence that induced nuclear localization of CD26 by the humanized anti-CD26 mAb, YS110, promotes transcriptional repression of the POLR2A gene, resulting in growth suppression of cancer cells. Here, POLR2A is linked to cancer.